<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Santoshm - Latest News</title>
<link href="https://news.newswirebiz.com/rss/santoshm/latest.xml"></link>
<updated>2026-07-21T10:32:53+00:00</updated>
<id>urn:uuid:52b36258-1420-dee5-bfbe-a0611f6562c3</id>
<entry>
<title>Global Cancer CDK Inhibitor Market</title>
<link href="https://news.newswirebiz.com/@santoshm/global-cancer-cdk-inhibitor-market-kn8rwaeyk3xw"></link>
<id>urn:uuid:3cb7f72c-de24-d306-237a-e73cf9193195</id>
<summary type="html"><![CDATA[The Global Cancer CDK Inhibitor Market accounted for US$ 6.0 billion in 2019 and is estimated to be US$ 16.1 billion by 2029 and is anticipated to register a CAGR of 10.4%.]]></summary>
<updated>2021-03-10T12:35:15+00:00</updated>
</entry>
</feed>